Carmignac

Carmignac P. Grande Europe: September 2023

Jump to a section on the page

Portfolio News

Annualized return - F EUR Acc Share Class

1MYTD1Y3Y5YMD
Carmignac Portfolio Grande Europe-3.34%+8.42%+18.23%+4.76%+7.42%+8.31%
Reference Indicator*-1.66%+8.52%+19.20%+10.32%+5.88%+6.87%


* Reference Indicator: Stoxx Europe 600 (NR, EUR). ** Mark Denham took over the fund on the 17/11/2016. Past performance is not necessarily indicative of future performance. Performance are net of fees (excluding possible entrance fees charges by distribution). The return may increase or decrease as a result of currency fluctuations. The fund presents a risk of capital loss. Source: Carmignac, Sept 2023.

Performance Review

  • TOP 3 CONTRIBUTORS

    • ZEALAD PHARMA Healthcare:   +0.39
    • NOVO NORDISK Healthcare:   +0.10
    • NORDNET Financials:   +0.10

  • TOP 3 DETRACTORS

    • LONZA Healthcare:   -0.77
    • STRAUMANN Healthcare:   -0.35
    • ASML Technology:   -0.31

Notable portfolio moves

  • New Positions: Beiersdorf (1.10%)

  • Reinforcements: Novo Nordisk (9.67%), Sanofi (3.80%), ASML (4.11%)

  • Reductions: AstraZeneca (1.00%), CapGemini (2.32%), Prudential (0.63%)

  • Positions Sold: Orsted, Adyen

  • Number of Holdings: 35 (target range 35/40)

Positioning

  • SECTOR ALLOCATION

    Carmignac

  • TOP 10 POSITIONS

    Carmignac

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. Portfolio holdings are subject to change and should not be considered a recommendation to buy or sell individual securities. Data as of 30/09/2023. Source: Carmignac, Sept 2023.

Strategy reminder

  • Investment Objective: The fund aims to outperform its reference indicator over a recommended investment horizon of five years.

  • An actively managed and concentrated European equity strategy.

  • 100% bottom-up.

  • High Conviction: 35 to 40 stocks on average.

  • SFDR Article 9 Strategy* with:

  • A fully integrated SRI approach
  • A sustainable investment objective

* Other investment restrictions apply. Please refer to the fund documentation for a complete description of the fund. **SFDR Fund Classification: Article 9 starting 1st January 2022. Sustainable Finance Disclosure Regulation (SFDR) 2019/2088.
For more information please refer to EUR-lex. Carmignac Portfolio Grande Europe obtained the French and Belgian SRI Labels: https://www.lelabelisr.fr/en/; https://www.towardssustainability.be/; https://www.febelfin.be/fr

  • Mark Denham
    Fund Manager
    Head of Equities

    Mark Denham is a Fund Manager and Head of Equities. Mark joined Carmignac in June 2016, from Aviva Investors where he was a Fund Manager and Head of Pan-European Equities. Prior to joining Aviva Investors in 2003, Mark occupied roles of Director of European Equities at Insight Investment and Fund Manager at National Mutual Life. He graduated from Cambridge University with a degree in Natural Sciences and holds a Postgraduate Certificate in Advanced Mathematics.

Carmignac Portfolio Grande Europe

A high conviction, sustainable European equity strategy

Discover the fund page

Carmignac Portfolio Grande Europe F EUR Acc

ISIN: LU0992628858

Recommended minimum investment horizon

Lower risk Higher risk

Potentially lower return Potentially higher return

1 2 3 4 5 6 7
Main risks of the Fund

EQUITY: The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.

CURRENCY: Currency risk is linked to exposure to a currency other than the Fund’s valuation currency, either through direct investment or the use of forward financial instruments.

DISCRETIONARY MANAGEMENT: Anticipations of financial market changes made by the Management Company have a direct effect on the Fund's performance, which depends on the stocks selected.

The Fund presents a risk of loss of capital.

Carmignac Portfolio Grande Europe F EUR Acc

ISIN: LU0992628858
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 (YTD)
?
Year to date
Carmignac Portfolio Grande Europe F EUR Acc +10.70 % -0.76 % +5.08 % +11.00 % -9.61 % +35.49 % +14.43 % +22.52 % -20.58 % +15.50 % +15.52 %
Reference Indicator +7.20 % +9.60 % +1.73 % +10.58 % -10.77 % +26.82 % -1.99 % +24.91 % -10.64 % +15.81 % +11.72 %

Scroll right to see full table

3 Years 5 Years 10 Years
Carmignac Portfolio Grande Europe F EUR Acc +4.54 % +10.43 % +7.87 %
Reference Indicator +7.53 % +8.46 % +7.05 %

Scroll right to see full table

Source: Carmignac at 30/09/2024

Maximum subscription fees paid to distributors : 0,00%
Redemption Fees : 0,00%
Ongoing Charges : 1.15%
Conversion Fee : 0%
Management Fees : 0,85%
Performance Fees : 20,00%
Thank you for taking the time to provide your feedback, appreciated.

Marketing communication. Please refer to the KID/KIID, prospectus of the fund before making any final investment decisions. This document is intended for professional clients.

This material may not be reproduced, in whole or in part, without prior authorisation from the Management Company. This material does not constitute a subscription offer, nor does it constitute investment advice. This material is not intended to provide, and should not be relied on for, accounting, legal or tax advice. This material has been provided to you for informational purposes only and may not be relied upon by you in evaluating the merits of investing in any securities or interests referred to herein or for any other purposes. The information contained in this material may be partial information and may be modified without prior notice. They are expressed as of the date of writing and are derived from proprietary and non-proprietary sources deemed by Carmignac to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by Carmignac, its officers, employees or agents.

Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor). The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.

Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice. The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.

Morningstar Rating™ : © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Access to the Funds may be subject to restrictions regarding certain persons or countries. This material is not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the material or availability of this material is prohibited. Persons in respect of whom such prohibitions apply must not access this material. Taxation depends on the situation of the individual. The Funds are not registered for retail distribution in Asia, in Japan, in North America, nor are they registered in South America. Carmignac Funds are registered in Singapore as restricted foreign scheme (for professional clients only). The Funds have not been registered under the US Securities Act of 1933. The Funds may not be offered or sold, directly or indirectly, for the benefit or on behalf of a «U.S. person», according to the definition of the US Regulation S and FATCA. The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital.

The Funds’ prospectus, KIDs, NAVs and annual reports are available at www.carmignac.com, or upon request to the Management Carmignac Portfolio refers to the sub-funds of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive. The French investment funds (fonds communs de placement or FCP) are common funds in contractual form conforming to the UCITS or AIFM Directive under French law.

  • In France, Luxembourg, Sweden: The risks, fees and ongoing charges are described in the KID (Key Information Document). The KID must be made available to the subscriber prior to subscription. The subscriber must read the KID. Investors may lose some or all their capital, as the capital in the funds are not guaranteed. The Funds present a risk of loss of capital. The Funds’ prospectus, KIDs, NAV and annual reports are available at www.carmignac.com, or upon request to the Management.

  • In the United Kingdom: the Funds’ respective prospectuses, KIIDs and annual reports are available at www.carmignac.co.uk, or upon request to the Management Company, or for the French Funds, at the offices of the Facilities Agent at BNP PARIBAS SECURITIES SERVICES, operating through its branch in London: 55 Moorgate, London EC2R. This document was prepared by Carmignac Gestion, Carmignac Gestion Luxembourg or Carmignac UK Ltd. FP Carmignac ICVC (the “Company”) is an Investment Company with variable capital incorporated in England and Wales under registered number 839620 and is authorised by the FCA with effect from 4 April 2019 and launched on 15 May 2019. FundRock Partners Limited is the Authorised Corporate Director (the “ACD”) of the Company and is authorised and regulated by the FCA. Registered Office: Hamilton Centre, Rodney Way, Chelmsford, Essex, CM1 3BY, UK; Registered in England and Wales with number 4162989. Carmignac Gestion Luxembourg SA has been appointed as the Investment Manager and distributor in respect of the Company. Carmignac UK Ltd (Registered in England and Wales with number 14162894) has been appointed as a sub-Investment Manager of the Company and is authorised and regulated by the Financial Conduct Authority with FRN:984288.

  • In Switzerland: the prospectus, KIDs and annual report are available at www.carmignac.ch, or through our representative in Switzerland, CACEIS (Switzerland), S.A., Route de Signy 35, CH-1260 Nyon. The paying agent is CACEIS Bank, Montrouge, Nyon Branch / Switzerland, Route de Signy 35, 1260 Nyon.

The Management Company can cease promotion in your country anytime. Investors have access to a summary of their rights in English on the following links: UK ; Switzerland ; France ; Luxembourg ; Sweden.